Jodi M. Carter

5.6k total citations
129 papers, 2.4k citations indexed

About

Jodi M. Carter is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Jodi M. Carter has authored 129 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 39 papers in Cancer Research and 38 papers in Oncology. Recurrent topics in Jodi M. Carter's work include Sarcoma Diagnosis and Treatment (28 papers), Breast Cancer Treatment Studies (26 papers) and Cancer Genomics and Diagnostics (18 papers). Jodi M. Carter is often cited by papers focused on Sarcoma Diagnosis and Treatment (28 papers), Breast Cancer Treatment Studies (26 papers) and Cancer Genomics and Diagnostics (18 papers). Jodi M. Carter collaborates with scholars based in United States, Canada and Sweden. Jodi M. Carter's co-authors include Andrew L. Folpe, JK Fraser, MV Berridge, Amy C. Degnim, Daniel W. Visscher, Robert J. Spinner, Karen Fritchie, Sharon W. Weiss, Derek C. Radisky and Konstantinos Linos and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jodi M. Carter

123 papers receiving 2.4k citations

Peers

Jodi M. Carter
Thomas A. Davis United States
Jodi M. Carter
Citations per year, relative to Jodi M. Carter Jodi M. Carter (= 1×) peers Thomas A. Davis

Countries citing papers authored by Jodi M. Carter

Since Specialization
Citations

This map shows the geographic impact of Jodi M. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jodi M. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jodi M. Carter more than expected).

Fields of papers citing papers by Jodi M. Carter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jodi M. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jodi M. Carter. The network helps show where Jodi M. Carter may publish in the future.

Co-authorship network of co-authors of Jodi M. Carter

This figure shows the co-authorship network connecting the top 25 collaborators of Jodi M. Carter. A scholar is included among the top collaborators of Jodi M. Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jodi M. Carter. Jodi M. Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leon‐Ferre, Roberto A., Jodi M. Carter, David M. Zahrieh, et al.. (2024). Automated mitotic spindle hotspot counts are highly associated with clinical outcomes in systemically untreated early-stage triple-negative breast cancer. npj Breast Cancer. 10(1). 25–25. 1 indexed citations
2.
Maldonado, Andrés A., Tomáš Marek, B. Matthew Howe, et al.. (2024). Neuromuscular choristoma-associated desmoid-type fibromatosis of the brachial plexus: Additional evidence to support a nerve-driven mechanism. Journal of Plastic Reconstructive & Aesthetic Surgery. 93. 83–91.
3.
Liu, Yuanhang, Robert A. Vierkant, Aditya Bhagwate, et al.. (2024). Evaluating cell type deconvolution in FFPE breast tissue: application to benign breast disease. NAR Genomics and Bioinformatics. 6(3). lqae098–lqae098. 1 indexed citations
4.
Degnim, Amy C., Robert A. Vierkant, Stacey J. Winham, et al.. (2024). Changes in breast cancer risk associated with benign breast disease from 1967 to 2013. JNCI Cancer Spectrum. 9(1).
5.
Maldonado, Andrés A., Stephen M. Broski, Jodi M. Carter, & Robert J. Spinner. (2023). Unrecognized neuromuscular choristoma with recurrent desmoid-type fibromatosis and Marjolin ulcer: expanding the spectrum of neuromuscular choristoma sequelae within the nerve territory? Illustrative case. Journal of Neurosurgery Case Lessons. 5(6). 2 indexed citations
6.
Scalise, Lorenzo, Jodi M. Carter, Robert T. Fazzio, et al.. (2023). Noninvasive prediction of axillary lymph node breast cancer metastasis using morphometric analysis of nodal tumor microvessels in a contrast-free ultrasound approach. Breast Cancer Research. 25(1). 65–65. 7 indexed citations
7.
Sukov, William R., Jain Zhou, Katherine B. Geiersbach, et al.. (2023). Frequency of HER2 protein overexpression and HER2 gene amplification in endometrial clear cell carcinoma. Human Pathology. 137. 94–101. 5 indexed citations
8.
Tang, Xiaojia, Kevin J. Thompson, Krishna R. Kalari, et al.. (2023). Integration of multiomics data shows down regulation of mismatch repair and tubulin pathways in triple-negative chemotherapy-resistant breast tumors. Breast Cancer Research. 25(1). 57–57. 2 indexed citations
9.
Degnim, Amy C., Brittany L. Siontis, Safia K. Ahmed, et al.. (2023). Trimodality Therapy Improves Disease Control in Radiation-Associated Angiosarcoma of the Breast. Clinical Cancer Research. 29(15). 2885–2893. 2 indexed citations
10.
Yu, Jia, Yongxian Zhuang, Xiaoyang Fan, et al.. (2022). Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast Cancer. Cancers. 14(17). 4220–4220. 11 indexed citations
11.
Thompson, Kevin J., Roberto A. Leon‐Ferre, Jason P. Sinnwell, et al.. (2022). Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response. NAR Cancer. 4(2). zcac018–zcac018. 26 indexed citations
12.
Wei, Lixuan, Huanyao Gao, Jia Yu, et al.. (2022). Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor–Positive Breast Cancer. Cancer Research. 83(3). 456–470. 17 indexed citations
13.
Carter, Jodi M., Mei‐Yin C. Polley, Roberto A. Leon‐Ferre, et al.. (2021). Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1–positive Triple-negative Breast Cancer. Clinical Cancer Research. 27(20). 5628–5637. 35 indexed citations
14.
Burgenske, Danielle M., Ann C. Mladek, Katrina K. Bakken, et al.. (2021). Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling Networks. Cancer Research. 81(14). 3930–3941. 19 indexed citations
15.
Boughey, Judy C., Vera J. Suman, Jia Yu, et al.. (2021). Patient-Derived Xenograft Engraftment and Breast Cancer Outcomes in a Prospective Neoadjuvant Study (BEAUTY). Clinical Cancer Research. 27(17). 4696–4699. 13 indexed citations
16.
Sherman, Mark E., Robert A. Vierkant, Tanya L. Hoskin, et al.. (2020). Breast Cancer Risk and Use of Nonsteroidal Anti-inflammatory Agents After a Benign Breast Biopsy. Cancer Prevention Research. 13(11). 967–976. 9 indexed citations
17.
Hawse, John R., Jodi M. Carter, Elizabeth S. Bruinsma, et al.. (2019). Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissues. Breast Cancer Research and Treatment. 179(1). 241–249. 34 indexed citations
18.
Degnim, Amy C., Tanya L. Hoskin, Marlene H. Frost, et al.. (2017). Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer Development. Clinical Cancer Research. 23(14). 3945–3952. 46 indexed citations
19.
Hieken, Tina J., Jodi M. Carter, John R. Hawse, et al.. (2015). ERβ Expression and Breast Cancer Risk Prediction for Women with Atypias. Cancer Prevention Research. 8(11). 1084–1092. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026